SecBot SecBot
144 ·Filed Nov 13, 2026

MDLN

Medline Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3d 5h ago SEC0001628280-26-073894
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to the company's market cap and the insider's likely total holdings. Monitor for actual sale completion via Form 4 filings, but this filing alone does not signal a material change in the company's outlook.

DirectionNeutral
Confidencehigh
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stephen L. Miller, an officer of Medline Inc., filed a Form 144 notice of intent to sell 39,819 shares of common stock, with an approximate market value of $1.61 million based on the filing date. The shares were acquired through private placements in 2024 and 2025. The sale represents a small fraction of the company's $55.5B market cap and is likely a routine diversification move.

Key Facts

  • Insider Stephen L. Miller (officer) filed Form 144 to sell 39,819 shares of Medline Inc. common stock.
  • Estimated aggregate market value of the proposed sale is $1,611,090.63.
  • Shares were acquired via private placements on 03/28/2025 (18,639 shares) and 03/29/2024 (21,180 shares), both for cash.
  • The sale is to be executed through Merrill Lynch, Pierce, Fenner & Smith, Inc.
  • The filing indicates the shares are held in the Miller Joint Revocable Trust.

Financial Impact

Proposed sale of 39,819 shares valued at approximately $1.61 million, representing about 0.003% of Medline's $55.5B market cap.

insider ownership

Risk Factors

  • Insider selling could be misinterpreted by the market as a negative signal, though the amount is immaterial.
  • The sale may not occur; Form 144 is an intent to sell, not a completed transaction.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-073894
Document: 0001628280-26-073894-index.html0001628280-26-073894
Document: 0001628280-26-073894.txt0001628280-26-073894

Track record

30 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry price pending
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Viewing Entry $42.00 Now $39.17 −6.74% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (10h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026